Large-scale testing (Phase 3)Study completedNCT06134804
What this trial is testing
9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older
Who this might be right for
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Janssen Research & Development, LLC 959